Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00031993 2013-01-17

Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix

Phase 2 Completed

Uterine Cervical Neoplasms